We are live on
!
Find out more
BHCM
Boulder Hill Capital Management Portfolio holdings
AUM
$47.9M
This Fund
S&P 500
This Quarter
Est. Return
+0.12%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$44.2M
(+50%)
Cap. Flow
+$59.2M
Cap. Flow
% of AUM
44.96%
Top 10 Holdings %
Top 10 Hldgs %
49.28%
Holding
217
New
125
Increased
7
Reduced
3
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$13.4M |
| 2 |
Illumina
ILMN
|
+$10.1M |
| 3 |
American Electric Power
AEP
|
+$9.78M |
| 4 |
Trade Desk
TTD
|
+$9.15M |
| 5 |
Hasbro
HAS
|
+$5.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$7.99M |
| 2 |
Ormat Technologies
ORA
|
+$2.69M |
| 3 |
Frontdoor
FTDR
|
+$2.57M |
| 4 |
iShares MSCI Mexico ETF
EWW
|
+$2.17M |
| 5 |
Antero Resources
AR
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.43% |
| 2 | Healthcare | 17.63% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Oneok
OKE
$54.5B
| $410K | 0.31% |
+8,000
| New | +$476K |
|
|
GMS
77
DELISTED
GMS Inc
GMS
| $408K | 0.31% |
+10,200
| New | +$488K |
|
|
CTRA
78
DELISTED
Coterra Energy
CTRA
| $407K | 0.31% |
+15,600
| New | +$447K |
|
79
Valero Energy
VLO
$85.9B
| $406K | 0.31% |
+3,800
| New | +$418K |
|
80
Corcept Therapeutics
CORT
$12B
| $400K | 0.3% |
+15,600
| New | +$417K |
|
81
IQVIA
IQV
$39.3B
| $399K | 0.3% |
+2,200
| New | +$482K |
|
82
Williams Companies
WMB
$86.1B
| $392K | 0.3% |
+13,700
| New | +$446K |
|
|
CTIC
83
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $392K | 0.3% |
+67,400
| New | +$420K |
|
84
Analog Devices
ADI
$190B
| $390K | 0.3% |
+2,800
| New | +$443K |
|
85
BlueLinx
BXC
$706M
| $388K | 0.29% |
+6,246
| New | +$450K |
|
86
Lithia Motors
LAD
$8.26B
| $386K | 0.29% |
+1,800
| New | +$470K |
|
87
Choice Hotels
CHH
$4.8B
| $383K | 0.29% |
+3,500
| New | +$401K |
|
88
Allogene Therapeutics
ALLO
$694M
| $378K | 0.29% |
+35,000
| New | +$476K |
|
89
Harmony Biosciences
HRMY
$2.24B
| $376K | 0.29% |
+8,500
| New | +$415K |
|
90
Leidos
LDOS
$17.3B
| $376K | 0.29% |
+4,300
| New | +$420K |
|
91
Tapestry
TPR
$32.8B
| $375K | 0.28% |
+13,200
| New | +$441K |
|
92
SLM Corp
SLM
$5.15B
| $369K | 0.28% |
+26,400
| New | +$409K |
|
93
Dollar Tree
DLTR
$25.2B
| $367K | 0.28% |
+2,700
| New | +$420K |
|
94
Steris
STE
$23.1B
| $366K | 0.28% |
+2,200
| New | +$448K |
|
95
Bunge Global
BG
$20.8B
| $363K | 0.28% |
+4,400
| New | +$410K |
|
96
Hudbay
HBM
$12.3B
| $358K | 0.27% |
+88,900
| New | +$356K |
|
97
Bumble
BMBL
$373M
| $357K | 0.27% |
+16,600
| New | +$491K |
|
98
HP
HPQ
$27.5B
| $356K | 0.27% |
+14,300
| New | +$439K |
|
99
NETSCOUT
NTCT
$2.79B
| $351K | 0.27% |
+11,200
| New | +$366K |
|
|
ITCI
100
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $349K | 0.26% |
+7,500
| New | +$392K |
|
Similar funds
MG
VMV
BHH
LAMC
MAM
BCM
CLCM
LOF
Boulder Hill Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Boulder Hill Capital Management held 217 positions worth $132M, up 50% from $87.6M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Boulder Hill Capital Management deployed $59.2M of net new capital in Q3 2022, opening 125 new positions and adding to 7 existing holdings. Its largest new stake was Adobe: 35,500 shares worth $9.77M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Organon & Co, an estimated $389K trimmed.
- Boulder Hill Capital Management's largest Q3 2022 buy was Adobe: 35,500 shares worth $9.77M.
- Boulder Hill Capital Management added most to State Street Energy Select Sector SPDR ETF in Q3 2022, an estimated $2.54M increase.
- Boulder Hill Capital Management's biggest Q3 2022 reduction was Organon & Co, cutting an estimated $389K.
- Boulder Hill Capital Management fully exited iShares Biotechnology ETF in Q3 2022, selling an estimated $7.99M.
- Boulder Hill Capital Management's ten largest holdings make up 49% of its $132M portfolio in Q3 2022.
- Boulder Hill Capital Management opened 125 new positions and closed 82 in Q3 2022.
- Boulder Hill Capital Management's portfolio value rose 50% quarter-over-quarter to $132M.
Based on Boulder Hill Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.